Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Scripps Research Scientists Reveal How… >
Scripps Research Scientists Reveal How Deadly Virus Silences Immune System

Published: September 14, 2012.
By Scripps Research Institute
http://www.scripps.edu

LA JOLLA, CA, September 13, 2012--Scientists at The Scripps Research Institute have determined the structure of a critical protein from the Marburg virus, a close cousin of Ebola virus. These viruses cause similar diseases and are some of the deadliest pathogens on the planet, each killing up to 90 percent of those infected.

The Marburg virus VP35 protein (beige) surrounds the virus´s double-stranded RNA (blue), masking it from immune system detection. Credit: Christina Corbaci, The Scripps Research Institute

Described in the September 13, 2012 publication of the journal PLoS Pathogens, the new research reveals how a key protein component of the Marburg virus, called VP35, blocks the human immune system, allowing the virus to grow unchecked. The structure provides a major step forward in understanding how the deadly virus works, and may be useful in the development of potential treatments for those infected.

"The immune system is designed to recognize certain hallmarks of virus infection," said Erica Ollmann Saphire, the Scripps Research scientist who led the effort. "When these are sensed, an immediate antiviral defense is launched. However, the Marburg and Ebola viruses mask the evidence of their own infection. By doing so, the viruses are able to replicate rapidly and overwhelm the patient's ability to launch an effective defense."

Deadly Outbreaks

Ebola virus outbreaks have occurred in the last month in both Uganda and the Democratic Republic of the Congo, while Marburg virus broke out in Angola in 2005 to 2006 and again in Uganda in 2007. The Angolan Marburg virus outbreak began in a pediatric ward and killed 88 percent of those it infected. The virus has since been imported into the United States (Colorado) and the Netherlands by tourists who had visited Africa.

There is currently no cure for Marburg hemorrhagic fever. The virus is spread when people come into contact with the bodily fluids of a person or animal who is already infected. The best treatment consists of administering fluids and taking protective measures to ensure containment, like isolating the patient and washing sheets with bleach.

Most people, however, die within two weeks of exposure from a combination of dehydration, massive bleeding, and shock. A smaller number of people have stronger and immediate immune responses against the virus and survive.

A New Roadmap for Defense

The breakthrough described in the PLoS Pathogens article explains a key reason why the viruses are so deadly and provides the necessary templates to develop drugs to treat the infection.

The study's lead author, Research Associate Shridhar Bale, explains that a key signature of Marburg virus infection is the double-stranded RNA that results from its replication inside cells. When human immune system proteins detect this virus-specific RNA, they sound an alarm to signal the rest of the immune system to respond. The new research describes how the VP35 protein of the Marburg virus binds to the viral double-stranded RNA and hides it to prevent the alarm from being sounded.

The new research also revealed a surprise. Images from the Marburg virus reveal the VP35 protein spirals around the double-stranded RNA, enveloping it completely. This is in contrast to previous images of the similar VP35 protein from Ebola virus that showed it only capping the ends of the RNA, leaving the center of the RNA helix exposed for possible recognition.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Virus 
9/10/13 
Scientists Engineer Strain of MERS Coronavirus for Use in a Vaccine
By American Society for Microbiology
Scientists have developed a strain of the Middle East respiratory syndrome coronavirus (MERS-CoV) that could be used as a vaccine against the disease, according to a study to be …
Lung 
4/30/13 
★★ 
Tactics of New Middle East Virus Suggest Treating by Altering Lung Cells' Response to Infection
By University of Washington
A new virus that causes severe breathing distress and kidney failure elicits a distinctive airway cell response to allow it to multiply. Scientists studying the Human Coronavirus-Erasmus Medical Center, …
Tumors 
2/25/13 
Virus Shows Promise as Prostate Cancer Treatment
By American Society for Microbiology
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of …
Marburg 
3/13/14 
Mount Sinai Scientists Discover How Marburg Virus Grows in Cells
By The Mount Sinai Hospital / Mount Sinai School of Medicine
New York, NY – A protein that normally protects cells from environmental stresses has been shown to interact Marburg virus VP24, allowing the deadly Marburg virus to live longer …
Virus 
11/17/10 
Structure of Lassa Virus Protein Reveals Viral Thievery
By Emory University
Scientists at Emory University and the University of St. Andrews have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can …
Genes 
1/27/12 
Study Offers New Information for Flu Fight
By University of Georgia
Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it. By first understanding the complex host cell …
Disease 
3/21/13 
Findings to Help in Design of Drugs Against Virus Causing Childhood Illnesses
By Purdue University
WEST LAFAYETTE, Ind. - New research findings may help scientists design drugs to treat a virus infection that causes potentially fatal brain swelling and paralysis in children. The …
System 
6/26/14 
★★★ 
Fighting Parasitic Infection Inadvertently Unleashes Dormant Virus
By Washington University School of Medicine
Signals from the immune system that help repel a common parasite inadvertently can cause a dormant viral infection to become active again, a new study shows. Further research …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition